GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sirona Biochem Corp (TSXV:SBM) » Definitions » Institutional Ownership

Sirona Biochem (TSXV:SBM) Institutional Ownership : 0.12% (As of May. 30, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Sirona Biochem Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Sirona Biochem's institutional ownership is 0.12%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Sirona Biochem's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Sirona Biochem's Float Percentage Of Total Shares Outstanding is 0.00%.


Sirona Biochem Institutional Ownership Historical Data

The historical data trend for Sirona Biochem's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sirona Biochem Institutional Ownership Chart

Sirona Biochem Historical Data

The historical data trend for Sirona Biochem can be seen below:

2018-12-31 2019-01-31 2019-02-28 2019-03-31 2019-04-30 2019-05-31 2019-06-30 2019-07-31 2019-08-31 2019-09-30
Institutional Ownership 1.95 1.95 0.86 0.66 0.66 0.28 0.22 0.22 0.27 0.12

Sirona Biochem Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Sirona Biochem (TSXV:SBM) Business Description

Traded in Other Exchanges
Address
C/o WeWork, 595 Burrard Street, Vancouver, BC, CAN, V7X 1L3
Sirona Biochem Corp is a development stage biotechnology company. The principal activities of the company are the development of cosmetic and pharmaceutical active ingredients which are licensed to partners in exchange for upfront, milestone, and royalty payments. The company acts as a cosmetic ingredient and drug discovery company with a proprietary technology platform with a specialization in the stabilization of carbohydrate molecules. It has a business presence in Canada and France.
Executives
Howard Jarman Verrico Director, Senior Officer

Sirona Biochem (TSXV:SBM) Headlines